GeneDx Holdings (WGS) EPS (Basic) (2020 - 2026)
GeneDx Holdings' (WGS) quarterly EPS (Basic) came in at -$0.6 in Q2 2026, down 257.88% year-over-year from $0.38 in Q2 2025, and up 72.34% quarter-over-quarter from -$2.16 in Q1 2026.
Powered by 
Analysis
GeneDx Holdings (WGS) EPS (Basic) (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported EPS (Basic) for 7 consecutive years, with -$0.6 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EPS (Basic) fell 257.88% year-over-year to -$0.6 in Q2 2026; TTM through Jun 2026 was -$3.58, a 7376.89% decrease from a year earlier, with the FY2025 full-year figure at -$0.73, up 62.25% from the prior year.
- EPS (Basic) was -$0.6 for Q2 2026 at GeneDx Holdings, up from -$2.16 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.38 in Q2 2025 and troughed at -$30.16 in Q4 2022.
- A 5-year average of -$3.26 and a median of -$0.92 in 2023 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) tumbled 8010.64% in 2022 and surged 134.52% in 2025, its largest moves.
- Over 5 years, EPS (Basic) stood at -$30.16 in 2022, then jumped by 96.48% to -$1.06 in 2023, then soared by 119.08% to $0.2 in 2024, then slumped by 405.01% to -$0.62 in 2025, then gained by 3.19% to -$0.6 in 2026.
- The last three EPS (Basic) figures came in at -$0.6 (Q2 2026), -$2.16 (Q1 2026), and -$0.62 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -0.47 |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 2.92 |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 3.66 |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -0.90 |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 0.05 |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 0.00 |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 0.19 |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 0.17 |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -0.10 |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | -0.60 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.60 |
| Mar 31, 2026 | -2.16 |
| Dec 31, 2025 | -0.62 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | 0.38 |
| Mar 31, 2025 | -0.23 |
| Dec 31, 2024 | 0.20 |
| Sep 30, 2024 | -0.31 |
| Jun 30, 2024 | -1.10 |
| Mar 31, 2024 | -0.78 |
| Dec 31, 2023 | -1.06 |
| Sep 30, 2023 | -1.64 |
| Jun 30, 2023 | -1.84 |
| Mar 31, 2023 | -3.04 |
| Dec 31, 2022 | -30.16 |
| Sep 30, 2022 | -6.72 |
| Jun 30, 2022 | -8.38 |
| Mar 31, 2022 | -0.31 |
| Dec 31, 2021 | -0.37 |
| Sep 30, 2021 | 0.18 |